Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Anti-Tuberculosis Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
... homecare markets. The global anti-tuberculosis therapeutics market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing prevalence ... Read More
-
Tuberculosis Diagnosis and Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, ... Read More
-
Tuberculosis Vaccine Treatment Industry Research Report 2023
... bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where ... Read More
-
Tuberculosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F
... Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition Global Tuberculosis Therapeutics Market is expected to grow at an impressive rate during ... Read More
-
Global Latent Tuberculosis Infection Screening Test Supply, Demand and Key Producers, 2023-2029
... of % CAGR during the forecast period (2023-2029). Latent tuberculosis infection (LTBI) screening tests are diagnostic tests used to identify individuals who have been infected with the bacteria that cause tuberculosis (TB) but do not ... Read More
-
Global Latent Tuberculosis Infection Screening Test Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War ... Read More
-
Pulmonary Tuberculosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
... Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Pulmonary Tuberculosis Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More
-
Global Antituberculosis Agent-9 Market Growth 2023-2029
... of % from 2023 to 2029. United States market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
... Infection (LTBI) Testing market finds that the global Latent Tuberculosis Infection (LTBI) Testing market reached a value of USD 1241.01 million in 2022. It’s expected that the market will achieve USD 2188.48 million by 2028, ... Read More
-
Mycobacterium Tuberculosis Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
... Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Mycobacterium Tuberculosis Tests market for ... Read More
-
Anti-Tuberculosis Therapeutics Market by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2023-2028
... reached US$ 1,354.79 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,991.34 Million by 2028, exhibiting a growth rate (CAGR) of 6.70% during 2023-2028. The rising healthcare spending, favorable reimbursement ... Read More
-
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032
... Microscopy Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End-User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; ... Read More
-
Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030
... Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User—Global Forecast to 2030 The global point-of-care diagnostics market is projected to reach ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size study & Forecast, by Diagnostics Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Other Diagnostic Test Types), by End-User (Hospitals/ Clinics, Diagnostics/ Research Laboratory, Other End-Users), and Regional Analysis, 2022-2029
... Other End-Users), and Regional Analysis, 2022-2029 Global Tuberculosis (TB) Diagnostics Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over ... Read More
-
Global Tuberculosis Vaccine Treatment Market Research Report 2023(Status and Outlook)
... the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates ... Read More
-
Global Tuberculosis TB Diagnostics Market Research Report 2023(Status and Outlook)
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Global Latent Tuberculosis Infection LTBI Testing Market Research Report 2023(Status and Outlook)
... Released Assay (IGRA), etc. Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc. Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy ... Read More
-
Global Tuberculosis TB Diagnostics Market Research Report 2023(Status and Outlook)
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Global Tuberculosis Vaccine Treatment Market Research Report 2023(Status and Outlook)
... the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates ... Read More
-
Global Active Tuberculosis Treatment Supply, Demand and Key Producers, 2023-2029
... the forecast period (2023-2029). This report studies the global Active Tuberculosis Treatment production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world market for Active Tuberculosis Treatment, ... Read More
-
Global Active Tuberculosis Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating ... Read More
-
Global Tuberculosis Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. ... Read More
-
Global Tuberculosis Screening Supply, Demand and Key Producers, 2023-2029
... period (2023-2029). This report studies the global Tuberculosis Screening demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market for Tuberculosis Screening, and provides market size (US$ ... Read More
-
Global Active Tuberculosis Treatment Market Growth 2023-2029
... a CAGR of % from 2023 to 2029. United States market for Active Tuberculosis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from ... Read More
-
Global Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029
... at a CAGR of % from 2023 to 2029. United States market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from ... Read More
Research Assistance
